GSID will discontinue its operations effective September  30, 2025.

We will not be able to formally collaborate with any research organizations or provide data, reagents, or vaccine product.

We want to thank all our collaborators and funders for their support over the past 21 years. We especially want to thank the Henry M. Jackson Foundation and the Bill & Melinda Gates Foundation for their generous financial support. Their funding enabled GSID to provide essential data and material to further advance the development of HIV vaccines.

We hope that the HIV scientific community continues to make progress towards a safe and effective vaccine in years to come. Your work is vital. Don't give up!

With much appreciation and gratitude,

The GSID team, past and present:
Carter Lee
Don Francis
Faruk Sinangil
Ian Francis
Keith Higgins
Lavon Riddle
Vineeta Gulati